Shepherd Financial Partners LLC acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 32,703 shares of the company’s stock, valued at approximately $4,202,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Addison Advisors LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at approximately $90,000. Comprehensive Financial Planning Inc. PA bought a new stake in Merck KGaA in the second quarter worth $134,000. Stevens Capital Partners bought a new stake in Merck KGaA in the second quarter worth $220,000. Kelman Lazarov Inc. purchased a new position in Merck KGaA during the second quarter worth $448,000. Finally, BOK Financial Private Wealth Inc. bought a new position in Merck KGaA during the second quarter valued at $523,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Trading Up 4.5%
Shares of MKGAF opened at $167.38 on Thursday. The company’s fifty day simple moving average is $162.50 and its 200-day simple moving average is $148.28. The company has a market cap of $21.63 billion, a P/E ratio of 25.55 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
